The federal Anti-Kickback Statute (AKS) is a key piece of legislation used by the government to prosecute healthcare businesses and practitioners for fraud. The law is broad, and applies to services billed by physicians, nurses and even diagnostic labs.
The government has stated it is prepared to go after those who commit health care fraud to receive funds set aside to help deal with the coronavirus pandemic. True to its word, the Department of Justice (DOJ) has already reported one action against health care fraud related to the coronavirus. The agency states it moved forward with an action against a website offering a free vaccine against COVID-19 - patients need only pay the $4.95 shipping and handling fee. It has since ordered the website to shut down the offer.
The Department of Justice recently accused a medical equipment manufacturer of violating the Anti-Kickback Statute (AKS). Whistleblowers began the claim, accusing the company of paying monetary incentives to suppliers and labs to better ensure these medical professionals used their sleep apnea equipment.
A diagnostic lab is in financial ruin after an insurer accused the lab of paying illegal kickbacks in exchange for referrals. The accusations are part of a lawsuit that has led the lab to file for protection in bankruptcy court.
Diagnostic and clinical labs may experience a surge in growth in coming years. A market research company recently released findings after analyzing the industry and found key factors that it believes predict an upcoming surge.